PRKAA1 and breast carcinoma: Gong et al. demonstrated that metformin could phosphorylate AMPKα1 and inhibit PKCγ, which suppressed the secretion of Hsp90α and invasion in the NSCLC cell line H1299 and breast cancer cell line MCF-7 but did not affect proliferation [102].